Clinical Trial Update: Safety, Pharmacokinetics and Efficacy of CT-707, Toripalimab and Gemcitabine in Advanced Pancreatic Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial update evaluating CT-707, toripalimab, and gemcitabine in advanced pancreatic cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• CT-707 (CT-707)
• Gemcitabine (Gemcitabine)
• Toripalimab (Toripalimab)

Snippet

Sponsor: Shouyao Holdings (Beijing) Co. LTD | Conditions: Advanced Pancreatic Cancer | Phase 1, Phase 2 | Status: UNKNOWN